United Drug acquires JVA

Healthcare firm United Drug has today announced that it has acquired the entire issued share capital of JVA Analytical Limited, a leading specialist analytical chemistry distributor based in Dublin.

JVA is a supplier of laboratory instrumentation, consumables, services and supplies to Ireland’s analytical, environmental, educational and regulatory laboratories.

The business currently employs 19 people, including senior management, all of whom will remain with the business.

The consideration for the acquisition is €16.5m in cash, payable on completion, plus an additional consideration of up to €4.5m payable based on achievement of agreed targets over the next 24 months.

"We are delighted to announce the acquisition of JVA," said United Drug chief executive, Liam FitzGerald.

"The company has a long established reputation as a high quality provider of equipment and services to the analytical chemistry sector in Ireland.

"JVA will form an important part of our medical & scientific division and broadens the range of customers to whom we provide support and services.

"I would like to welcome all management and staff of JVA to the United Drug Group and we look forward to working with them to build upon their success to date, as we continue our development as a leading international healthcare services company."